Sarepta Therapeutics SRPT
NASDAQ SRPT
$22.00 +1.06 (+5.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026)

Sarepta Therapeutics (SRPT) posted Prepaid Assets of $105.8 million for Q2 2026, down 43.72% on a QoQ basis from $188.0 million in Q1 2026, and down 17.09% year-over-year from $127.6 million in Q2 2025.

Analysis

Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026) Analysis & Trends

Sarepta Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $105.8 million in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 17.09% year-over-year to $105.8 million in Q2 2026; TTM through Jun 2026 was $105.8 million, a 17.09% decrease from a year earlier, with the FY2025 full-year figure at $171.9 million, up 89.98% from the prior year.
  • Prepaid Assets was $105.8 million for Q2 2026 at Sarepta Therapeutics, down from $188.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $192.3 million in Q3 2025, with the low at $74.7 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $134.2 million, with a median of $135.5 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets tumbled 53.85% in 2024, then soared 89.98% in 2025.
  • Over 5 years, Prepaid Assets stood at $149.9 million in 2022, then plunged by 48.15% to $77.7 million in 2023, then gained by 16.4% to $90.5 million in 2024, then jumped by 89.98% to $171.9 million in 2025, then sank by 38.45% to $105.8 million in 2026.
  • The last three Prepaid Assets figures came in at $105.8 million (Q2 2026), $188.0 million (Q1 2026), and $171.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn
10 Taysha Gene Therapies 1.82 Bn 1.82 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.78 Mn
Mar 31, 2026 187.97 Mn
Dec 31, 2025 171.86 Mn
Sep 30, 2025 192.35 Mn
Jun 30, 2025 127.59 Mn
Mar 31, 2025 105.48 Mn
Dec 31, 2024 90.46 Mn
Sep 30, 2024 165.48 Mn
Jun 30, 2024 74.74 Mn
Mar 31, 2024 82.97 Mn
Dec 31, 2023 77.71 Mn
Sep 30, 2023 154.44 Mn
Jun 30, 2023 148.22 Mn
Mar 31, 2023 179.77 Mn
Dec 31, 2022 149.89 Mn
Sep 30, 2022 130.74 Mn
Jun 30, 2022 129.33 Mn
Mar 31, 2022 140.33 Mn
Dec 31, 2021 149.03 Mn
Sep 30, 2021 147.94 Mn